Enimmune Corporation (TPEX:6564)
Taiwan · Delayed Price · Currency is TWD 14.90
-0.40 (-2.61%)
Oct 30, 2026, 1:18 PM CST
Enimmune Market Cap
Enimmune has a market cap or net worth of 1.07 billion as of October 30, 2026. It is the 34,358th most valuable company in the world and the 2,072nd biggest in Taiwan. Its market cap has decreased by 27.32% in one year.
Market Cap
1.07B
Enterprise Value
1.06B
Revenue
53.45M
Global Rank
Country Rank
#2,072 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2018, Enimmune's market cap has decreased from 1.33B to 1.07B, a decrease of -19.09%. That is a compound annual growth rate of -2.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.07B | -27.67% |
| Dec 31, 2025 | 1.49B | -17.27% |
| Dec 31, 2024 | 1.80B | -27.21% |
| Dec 29, 2023 | 2.47B | -38.63% |
| Dec 30, 2022 | 4.02B | 69.85% |
| Dec 30, 2021 | 2.37B | -11.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.43B |
| Abnova (Taiwan) | 1.25B |
| NeoCore Technology | 1.22B |
| Bio Preventive Medicine | 1.14B |
| LabTurbo Biotech | 1.11B |
| Level Biotechnology | 993.06M |
| BiOptic | 992.66M |
| Holy Stone Healthcare | 966.35M |